When implanted into the submucosa, the Smyd2 deficient MC-38 cells resulted in tumors that had a significantly reduced tumor size and lower tumor scores (Fig. 1D, E), which was similar to the results obtained from the subcutaneous injection experiment. The gene discussed is SMYD2; the disease is neoplasm.